Zofran (HCID 59774)

概要

Ondansetron hydrochloride is a member of carbazoles.

名称と識別子

優先名称: Zofran
IUPAC: 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;dihydrate;hydrochloride
現地名: オンダンセトロン塩酸塩二水和物
英語名: Ondansetron hydrochloride
分子式: C18H22ClN3O2
分子量: 347.84

名称と別名

ZofranRefChem:934563Ondansetron hydrochloride dihydrate103639-04-9Ondansetron hydrochloride hydrateSetrodonDTXSID90488579-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one;dihydrate;hydrochlorideGR-38032FMFCD00374371CHEBI:7774DTXCID6028783

名称をさらに表示

9‐メチル‐3‐［（2‐メチル‐1H‐イミダゾール‐1‐イル）メチル］‐1，2，3，4‐テトラヒドロ‐9H‐カルバゾール‐4‐オン·塩酸塩·二水和物オンダンセトロン塩酸塩二水和物1,2,3,9-テトラヒドロ-9-メチル-3-[(2-メチル-1H-イミダゾール-1-イル)メチル]-4H-カルバゾール-4-オン塩酸塩二水和物オンダンセトロン塩酸塩 DIHYDRATEオンダンセトロンヒドロクロリドオンダンセトロン塩酸塩二水和物オンダンセトロン塩酸塩水和物オンダンセトロン塩酸塩水和物 (JAN)9-メチル-3-[(2-メチル-1H-イミダゾール-1-イル)メチル]-1,2,3,4-テトラヒドロ-9H-カルバゾール-4-オン・塩酸塩・二水和物9-メチル-3-(2-メチル-1H-イミダゾール-1-イルメチル)-1,2,3,4-テトラヒドロカルバゾール-4-オン=塩酸塩=二水化物AKOS NCG1-0013ondansetron hydOndansetronHclUsp28Ondansetron hydrochlODANSETRON HYDROCHLORIDEOndansetron hydrochloridOndansetronHClmonohydrateOndansetron hydrochlorideGR 38032SN 307NSC 665799Ondansetron impurity A CRS

Ondansetron (hydrochloride dihydrate)9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrateKS-1091ONDANSETRON HYDROCHLORIDE [MART.]CAS-103639-04-94H-Carbazol-4-one,1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-,monohydrochloride, dihydrateUNII-NMH84OZK2BZensana

データベース識別子

CAS: 103639-04-9
PubChem CID: 59774
DTXSID: DTXSID9048857
ChEBI: CHEBI:7774
UNII: NMH84OZK2B
EC Number: 600-465-5

物性

構造計算による物性

極性表面積: 41.8 Å²
水素結合供与体数: 3
水素結合受容体数: 4
回転可能結合数: 2
重原子数: 25
形式電荷: 0
複雑度: 440

実験および物理化学的性質

Human DrugsBreast Feeding; Lactation; Milk, Human; Antiemetics; Gastrointestinal Agents; Serotonin Antagonists; Serotonin 5-HT3 Receptor Antagonists

物理化学的性質

融点: 231 · 231-232 C
貯蔵温度: -20 °C · -20°C
溶解性: 2 O: · H2O: >5mg/mL
外見: 粉
色: 白い
水溶解度: 2 O: · H2O: >5mg/mL
InChI: InChI=1S/C18H19N3O.ClH.H2O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H;1H2
InChIKey: FELGMEQIXOGIFQ-ZDUSSCGKSA-N
SMILES: O=C1C(CCC2N(C)C3=CC=CC=C3C1=2)CN1C=CN=C1C.Cl.O
CAS データベース: 103639 · 103639-04-9(CAS DataBase Reference)

化学的性質

化学的特性White or almost white powder.

安全と法規制

GHS分類

GHS Classification · 4 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P264+P265, P270, P273, P280, P301+P316, P305+P351+P338, P305+P354+P338, P317, P321, P330, P337+P317, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 117 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 3 (100%)

毒性情報

TreatmentThere is no specific antidote for ondansetron overdose. Patients should be managed with appropriate supportive therapy. (L1712)

Exposure RoutesOndansetron is well absorbed after oral administration and undergoes limited first-pass metabolism.

Toxicity Summary · 1 件

Ondansetron is a selective serotonin 5-HT3 receptor antagonist. The antiemetic activity of the drug is brought about through the inhibition of 5-HT3 receptors present both centrally (medullary chemoreceptor zone) and peripherally (GI tract). This inhibition of 5-HT3 receptors in turn inhibits the visceral afferent stimulation of the vomiting center, likely indirectly at the level of the area postrema, as well as through direct inhibition of serotonin activity within the area postrema and the chemoreceptor trigger zone.

Signs and SymptomsLow blood pressure and fainting, sudden blindness, severe constipation

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

wgk: 3
rtecs: FE6375500
ridadr: UN 2811
hs_code: 2933290000
risk_code: 25-36/37/38-50/53-41
hazard_code: T,Xi
safety_code: 45-37/39-26-61-39
hazard_class: 6.1
packing_group: III
Hazard Classifications: Acute Tox. 3 OralAquatic Acute 1Aquatic Chronic 2Eye Dam. 1
ストレージクラス: 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

化学と産業

薬理情報

Metabolism/MetabolitesHepatic Half Life: 5.7 hours

MeSH Pharmacological Classification · 3 件

Drugs used to prevent NAUSEA or VOMITING.

Agents, usually topical, that relieve itching (pruritus).

Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS.

用途と製造

UsesFor the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, postoperation, and radiation. Also used for the treatment of postoperative nausea and vomiting.

応用分野 · 3 件

説明Ondansetron hydrochloride is a selective 5HT3-antagonist approved for the management of nausea and vomiting induced by cancer chemotherapy and radiotherapy. It is reported to have a superior side-effect profile compared with metoclopramide, representing an important advance in the treatment of nausea and vomiting associated with chemotherapy. Ondansetron hydrochloride is the first specific 5HT3-antagonist to reach the market. It is also under investigation for a number of other indications, including anxiety and schizophrenia.

使用Ondansetron hydrochloride dihydrate has been used as a 5-HT3 antagonist to attenuate rostro ventromedial medulla (RVM)/cholecystokinin (CCK)-induced mechanical hypersensitivity and to block the effects of trichostatin A (TSA) on 5-HT3 protein.

一般的な説明Ondansetron Hydrochloride acts as a 5HT3 (serotonin) antagonist and is a powerful antiemetic drug. It is widely used for the prevention and treatment of nausea and vomiting related to post-operative states, cancer chemotherapy and radiotherapy, and chronic medical illness. It has been found to exhibit inconsistent bioavailability resulting from its poor aqueous solubility and high first-pass hepatic metabolism.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.